ANALYSIS: Demand For Pfizer’s COVID Pills Lags Around The World

PARIS, France – Worldwide demand for Pfizer Inc’s oral COVID-19 antiviral treatment Paxlovid has been unexpectedly light due to complicated eligibility requirements, reduced testing, and potential for drug interactions, a Reuters review of data and interviews with experts has found. Demand also has been hampered by the perception that Omicron infections are not that severe. … More ANALYSIS: Demand For Pfizer’s COVID Pills Lags Around The World

Advertisement